Works matching IS 08909091 AND DT 2012 AND VI 26 AND IP 10
Results: 28
Controversies in the Pathology of Thymoma Viewed Through the Prism of Evidence-Based Pathology.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Thymoma: Current Concepts.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Consultations In Ethics.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 995
- By:
- Publication type:
- Article
SUPPORTIVE CARE.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 994
- By:
- Publication type:
- Article
ETHICS AND ONCOLOGY.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 993
- By:
- Publication type:
- Article
Relative Roles of Targeted Therapies and Immunotherapies in Melanoma.
- Published in:
- 2012
- Publication type:
- Interview
Thymomas: A Continuing Challenge.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 984
- By:
- Publication type:
- Article
Can Bone-Targeted Therapy Reduce Recurrence and Improve Survival in Early-Stage Breast Cancer?
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 969
- By:
- Publication type:
- Article
Sixty Is the New Forty-or Is It the Other Way Around?
- Published in:
- 2012
- By:
- Publication type:
- Opinion
Bone-Modifying Agents as Adjuvant Therapy for Early-Stage Breast Cancer.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 955
- By:
- Publication type:
- Article
Improving Harmonious Precision.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 949
- By:
- Publication type:
- Article
Targeted Therapy for Cancer: Asking the Right Questions.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 947
- By:
- Publication type:
- Article
Targeted Therapy: Its Status and Promise in Selected Solid Tumors Part I: Areas of Major Impact.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 936
- By:
- Publication type:
- Article
Preliminary results of vaccine study warrant further testing.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 935
- Publication type:
- Article
Early results of mTOR inhibitor for triple-negative breast cancer.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 931
- Publication type:
- Article
First-Line Erlotinib Inferior to Chemo in Advanced Lung Cancer.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 930
- Publication type:
- Article
Epigenetic Change in DNA Structure May Serve as Marker for Melanoma.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 930
- Publication type:
- Article
The Cost of Cancer Care: There Is More Than One Elephant in the Room.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 926
- By:
- Publication type:
- Article
Healthcare Financing and the Cost of Cancer Care.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 924
- By:
- Publication type:
- Article
The Cost of Cancer Care: Part I.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 918
- By:
- Publication type:
- Article
New Approaches for Triple-Negative Breast Cancer.
- Published in:
- 2012
- Publication type:
- Abstract
Evidence That Diet During Youth Influences Breast Cancer Risk.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 895
- Publication type:
- Article
New Device May Reduce Additional Surgeries in Breast Cancer Patients.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 916
- Publication type:
- Article
Front-Line TKI Therapy for Chronic-Phase CML: the Luxury of Choice.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
Is Imatinib Still an Acceptable First-Line Treatment for CML in Chronic Phase?
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 901
- By:
- Publication type:
- Article
USPSTF Says No Screening for Ovarian Cancer in New Guidelines.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 896
- Publication type:
- Article
FDA Approves Regorafenib (Stivarga) for Metastatic Colorectal Cancer.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 896
- Publication type:
- Article
Which TKI Should Be Recommended as Initial Treatment for CML in Chronic Phase?
- Published in:
- 2012
- By:
- Publication type:
- Opinion